Revolade 25 mg powder for oral suspension

Licence status
Authorised: 04/04/2016
Active substances
Eltrombopag olamine
Dosage Form
Powder for oral suspension
Licence number
EU/1/10/612/013
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
B02BX Other systemic hemostatics, B02BX05 eltrombopag
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
04/04/2016